Targeting activated T cells: Successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis [1]

H. U. Scherer; G. R. Burmester; G. Riemekasten

doi:10.1136/ard.2005.046938

Targeting activated T cells: Successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis [1]

H. U. Scherer^*
, G. R. Burmester
, G. Riemekasten

^*Corresponding author for this work

Department of Rheumatology and Clinical Immunology

Charite - Universitatsmedizin Berlin

33 Citations (Scopus)

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	65
Issue number	9
Pages (from-to)	1245-1247
Number of pages	3
ISSN	0003-4967
DOIs	https://doi.org/10.1136/ard.2005.046938
Publication status	Published - 09.2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1136/ard.2005.046938

Cite this

@article{de57bb54456a47a5894aa3335991178f,

title = "Targeting activated T cells: Successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis [1]",

author = "Scherer, \{H. U.\} and Burmester, \{G. R.\} and G. Riemekasten",

year = "2006",

month = sep,

doi = "10.1136/ard.2005.046938",

language = "English",

volume = "65",

pages = "1245--1247",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier B.V.",

number = "9",

}

TY - JOUR

T1 - Targeting activated T cells: Successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis [1]

AU - Scherer, H. U.

AU - Burmester, G. R.

AU - Riemekasten, G.

PY - 2006/9

Y1 - 2006/9

UR - https://www.scopus.com/pages/publications/33747809325

U2 - 10.1136/ard.2005.046938

DO - 10.1136/ard.2005.046938

M3 - Letters

C2 - 16905582

AN - SCOPUS:33747809325

SN - 0003-4967

VL - 65

SP - 1245

EP - 1247

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 9

ER -

Targeting activated T cells: Successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis [1]

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this